Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML)
Alamanda, Cut Nur Cinthia
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Medicine & Pharmacology Neuroscience

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Comparison of Molecular Testing Methods in Detecting Drug Resistance Tuberculosis Yanika, Grevy; Alamanda, Cut Nur Cinthia; Rachman, Rifky Waluyajati
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 31 No. 1 (2024)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v31i1.2295

Abstract

Tuberculosis (TB) is the leading cause of infectious disease-related deaths in Indonesia, and the COVID-19 pandemic has led to a decline in TB reporting and an increase in Drug-Resistant Tuberculosis (DR-TB). While traditional culture and Drug Susceptibility Testing (DST) takes 2-8 weeks, therefore, genotypic assays such as GeneXpert, Line Probe Assay (LPA), and sequencing offer faster and more precise diagnosis and drug resistance information.
Assessing the Efficacy of Dengue Vaccine: A Comprehensive Literature Review Agustina, Angelia; Alamanda, Cut Nur Cinthia
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 31 No. 2 (2025)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v31i2.2415

Abstract

Dengue fever remains a major global public health issue, especially in tropical nations like Indonesia, where cases of Dengue Hemorrhagic Fever (DHF) continue to increase annually. Despite extensive efforts in mosquito vector control programs, the transmission of dengue fever continues. World Health Organization (WHO) recommends vaccination as a potential option that can be used in endemic areas such as Indonesia. This literature review aims to collect and analyze the latest evidence on the efficacy and effectiveness of dengue vaccines based on findings from current relevant research. Dengvaxia, TAK-003, and TV003/TV005 are potential vaccines to provide immunity and prevent dengue infections with efficacy of Dengvaxia, DENV 3 and 4 70-80%, DENV 1 and 2 40-50%; TAK-003 seropositive 76.1%, seronegative 66.2% and TV003/TV005 seropositive 89.2% seronegative 73.6% (1-6). Additionally, TV003/TV005 can be used for travelers to endemic areas, as a single-dose administration and has been shown to provide immunity regardless of serostatus.
Co-Authors Agustina, Angelia Rachman, Rifky Waluyajati Yanika, Grevy